Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
16 studies found for:    WILSON DISEASE
Show Display Options
Rank Status Study
1 Completed
Has Results
Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
Condition: Wilson Disease
Intervention: Drug: Once a day Trientine
2 Recruiting The Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment
Condition: Wilson Disease
Intervention:
3 Completed
Has Results
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Condition: Wilson's Disease
Intervention: Drug: NPC-02
4 Recruiting sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis
Condition: Wilsons Disease
Interventions: Procedure: Fibroscan;   Procedure: Ultrasound;   Drug: Galactose;   Procedure: Liver biopsy;   Procedure: Functional hepatic nitrogen clearance
5 Active, not recruiting Efficacy and Safety Study of WTX101 in Adult Wilson Disease Patients
Condition: Wilson Disease
Intervention: Drug: WTX101
6 Completed A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
Condition: Wilson's Disease
Intervention: Drug: trientine dihydrochloride
7 Recruiting Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
Condition: Wilson Disease
Intervention: Drug: trientine dihydrochloride
8 Not yet recruiting WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)
Conditions: Severe Dystonia;   Wilson's Disease
Interventions: Device: Medtronic, Activa® PC "on";   Device: Medtronic, Activa® PC "off"
9 Completed Study of Zinc for Wilson Disease
Condition: Wilson Disease
Intervention: Drug: zinc acetate
10 Completed Study of Tetrathiomolybdate in Patients With Wilson Disease
Condition: Wilson Disease
Interventions: Drug: tetrathiomolybdate;   Drug: trientine
11 Recruiting Inhibitory rTMS in Dystonic Wilson Patients
Conditions: Wilson Disease;   Movement Disorders;   Repetitive Transcranial Magnetic Stimulation
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS);   Other: pre and post-rTMS electroencephalogram;   Other: WCRS;   Other: handwriting scale DPRE;   Other: visual analog scale of discomfort writing and parameters collected on touchpad
12 Completed Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis
Condition: Wilson's Disease
Intervention: Genetic: allogeneic mesenchymal stem cell transplantation
13 Recruiting ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
Conditions: Movement Disorders;   Essential Tremor;   Holmes Tremor;   Parkinson's Disease;   Wilson's Disease;   Huntington's Disease;   Dystonia;   Tardive Dyskinesia;   Orofacial Dyskinesias
Intervention: Device: Transcranial ExAblate System
14 Completed Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Condition: Wison's Disease
Intervention: Drug: Zinc acetate
15 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
16 Terminated A Study to Identify and Characterize LAL-D Patients in High-risk Populations
Condition: Lysosomal Acid Lipase Deficiency
Intervention:

Indicates status has not been verified in more than two years